Cargando…
Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project
PURPOSE: Although treatment for early breast cancer improved prognosis greatly, it can have significant long-term consequences, which must be considered during treatment decision. METHODS: 453 patients with neoadjuvant or adjuvant treatment intention were recruited into the MaTox project within the...
Autores principales: | Hurtz, Hans-Jürgen, Tesch, Hans, Göhler, Thomas, Hutzschenreuter, Ulrich, Harde, Johanna, Kruggel, Lisa, Jänicke, Martina, Marschner, Norbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602000/ https://www.ncbi.nlm.nih.gov/pubmed/28677012 http://dx.doi.org/10.1007/s10549-017-4365-7 |
Ejemplares similares
-
Quality of life in pre- and postmenopausal patients with early breast cancer: a comprehensive analysis from the prospective MaLife project
por: Marschner, Norbert, et al.
Publicado: (2019) -
Adjuvant chemotherapeutic treatment of 1650 patients with early breast cancer in routine care in Germany: data from the prospective TMK cohort study
por: Dörfel, Steffen, et al.
Publicado: (2017) -
Routine treatment and outcome of breast cancer in younger versus elderly patients: results from the SENORA project of the prospective German TMK cohort study
por: Fietz, Thomas, et al.
Publicado: (2017) -
Treatment and outcome in metastatic lobular breast cancer in the prospective German research platform OPAL
por: Thill, M., et al.
Publicado: (2023) -
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer
por: Drooger, Jan C., et al.
Publicado: (2016)